9-105535122-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145313.3(FSD1L):c.1182T>A(p.Asp394Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145313.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSD1L | NM_001145313.3 | c.1182T>A | p.Asp394Glu | missense_variant | 12/14 | ENST00000481272.6 | NP_001138785.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSD1L | ENST00000481272.6 | c.1182T>A | p.Asp394Glu | missense_variant | 12/14 | 2 | NM_001145313.3 | ENSP00000417492.1 | ||
FSD1L | ENST00000374707.1 | c.525T>A | p.Asp175Glu | missense_variant | 6/8 | 1 | ENSP00000363839.1 | |||
FSD1L | ENST00000394926.7 | c.1119T>A | p.Asp373Glu | missense_variant | 12/14 | 5 | ENSP00000378384.3 | |||
FSD1L | ENST00000484973.5 | c.1083T>A | p.Asp361Glu | missense_variant | 11/13 | 2 | ENSP00000419691.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.1182T>A (p.D394E) alteration is located in exon 12 (coding exon 12) of the FSD1L gene. This alteration results from a T to A substitution at nucleotide position 1182, causing the aspartic acid (D) at amino acid position 394 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at